Piedāvājumi

Vēl piedāvājumi, lapa 41845

Katram piedāvājumam zemāk ir 13–97% atlaide. Cenas tiek sinhronizētas reāllaikā no pārbaudītiem veikaliem.

Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS): Canvas Business Model
-22%

Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS): Canvas Business Model

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS): BCG Matrix [Dec-2025 Updated]
-22%

Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS): Ansoff Matrix
-22%

Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS): Ansoff Matrix

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS) DCF Valuation
-40%

Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS) DCF Valuation

dcfmodeling.comPLPL
15,00 PLN25,00 PLN
Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS): PESTLE Analysis [Dec-2025 Updated]
-22%

Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS): Marketing Mix Analysis
-22%

Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS): Marketing Mix Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS): 5 FORCES Analysis [Dec-2025 Updated]
-22%

Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS): SWOT Analysis [Dec-2025 Updated]
-22%

Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS): Canvas Business Model
-22%

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS): Canvas Business Model

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS): BCG Matrix [Dec-2025 Updated]
-22%

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS): Ansoff Matrix
-22%

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS): Ansoff Matrix

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS): VRIO Analysis
-22%

Zhejiang Shengyang Science and Technology Co., Ltd. (603703.SS): VRIO Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS): Marketing Mix Analysis
-22%

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS): Marketing Mix Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) DCF Valuation
-40%

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) DCF Valuation

dcfmodeling.comPLPL
15,00 PLN25,00 PLN
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS): PESTLE Analysis [Dec-2025 Updated]
-22%

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS): 5 FORCES Analysis [Dec-2025 Updated]
-22%

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Jiajiayue Group Co., Ltd. (603708.SS): Ansoff Matrix
-22%

Jiajiayue Group Co., Ltd. (603708.SS): Ansoff Matrix

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS): VRIO Analysis
-22%

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS): VRIO Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS): SWOT Analysis [Dec-2025 Updated]
-22%

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Jiajiayue Group Co., Ltd. (603708.SS): BCG Matrix [Dec-2025 Updated]
-22%

Jiajiayue Group Co., Ltd. (603708.SS): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Jiajiayue Group Co., Ltd. (603708.SS): Marketing Mix Analysis
-22%

Jiajiayue Group Co., Ltd. (603708.SS): Marketing Mix Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Jiajiayue Group Co., Ltd. (603708.SS): Canvas Business Model
-22%

Jiajiayue Group Co., Ltd. (603708.SS): Canvas Business Model

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Jiajiayue Group Co., Ltd. (603708.SS) DCF Valuation
-40%

Jiajiayue Group Co., Ltd. (603708.SS) DCF Valuation

dcfmodeling.comPLPL
15,00 PLN25,00 PLN
Jiajiayue Group Co., Ltd. (603708.SS): PESTLE Analysis [Dec-2025 Updated]
-22%

Jiajiayue Group Co., Ltd. (603708.SS): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN